Deep immune characterization of tumor microenvironment on high dimensional image features from multiplexed IHC staining may provide insightful directions on finding and validating predictive markers for PD-1/PD-L1 blockage and other immunotherapies. This evidence concerns the gene RPL17 and neoplasm.